Editorial
Published on 14 Mar 2023
Editorial: Prognostic factors in non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1174625
- 1,254 views
- 1 citation
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,600 articles
Articles
Original Research
Published on 14 Mar 2023
Cost-effectiveness evaluation based on two models of first-line atezolizumab monotherapy and chemotherapy for advanced non-small cell lung cancer with high-PDL1 expression
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1093469
- 2,386 views
Case Report
Published on 14 Mar 2023
Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1134151
- 2,405 views
- 7 citations
Original Research
Published on 13 Mar 2023
Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1092478
- 4,052 views
- 6 citations
Original Research
Published on 13 Mar 2023
Adjuvant EGFR-TKI therapy in resected EGFR-mutation positive non-small cell lung cancer: A real-world study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1132854
- 2,210 views
Brief Research Report
Published on 13 Mar 2023
Heterogeneity of tumour mutational burden in metastatic NSCLC demonstrated by endobronchial ultrasound sampling
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1150349
- 1,532 views
- 5 citations
Case Report
Published on 10 Mar 2023
Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1145021
- 2,471 views
- 1 citation
Mini Review
Published on 09 Mar 2023
The use of nanoparticles for targeted drug delivery in non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1154318
- 4,781 views
- 13 citations
Study Protocol
Published on 09 Mar 2023
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1136221
- 6,727 views
- 4 citations
Review
Published on 09 Mar 2023
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1120828
- 3,730 views
- 1 citation
Original Research
Published on 09 Mar 2023
Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1113696
- 3,737 views
- 3 citations
Review
Published on 08 Mar 2023
Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1027659
- 1,544 views
- 1 citation
Brief Research Report
Published on 08 Mar 2023
Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1018288
- 1,911 views
Review
Published on 07 Mar 2023
The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1133164
- 4,093 views
- 10 citations
Original Research
Published on 07 Mar 2023
A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1066360
- 1,694 views
- 9 citations
Original Research
Published on 06 Mar 2023
Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1128443
- 2,935 views
- 4 citations